Mental health apps more popular

People are looking for apps that could support their mental health, according to market analysts onefourzero and GK (https://onefourzerogroup.com). Their report The Rise of Digital Doctors analysed online data for apps and over 34,000 posts on social media, review sites and forums to find that …

More details...

Progress on migraine treatments

Allergan has reported that its calcitonin gene receptor peptide (CGRP) antagonist atogepant met the primary endpoint in a Phase IIb/III efficacy trial for preventing episodic migraine involving 795 patients. In patients reporting 4 – 14 migraine/probable migraine (MPM) headache days per month, atogepant 30 mg …

More details...

Nurturing family reduces mental health risk

A child whose mother has a mental illness but has been part of a nurturing family environment, pre and post pregnancy, is less likely to suffer from a mental disorder in later life compared to those who grew up in a less supportive environment, according …

More details...

More effective MS treatments increase productivity

Disease-modifying therapies (DMTs) for multiple sclerosis (MS) that are most effective are more likely to increase work attendance, work carried out and productivity than less effective alternatives, say Australian investigators (J Neurol Neurosurg Psychiatry: 19 June 2018. doi: 10.1136/jnnp-2018-318228).
They reviewed data from the Australian MS …

More details...

Cannabis effective in childhood epilepsy, review finds

After the recent controversy surrounding the Home Office’s confiscation and subsequent return of medicinal cannabis used to treat a child’s epilepsy prompted a review of legislation by the Home Office (www.gov.uk/government/news/home-office-launches-review-into-medical-use-of-cannabis), specialists in the UK and Australia have published a timely systematic review of its …

More details...

Schizophrenia mortality still high

Life expectancy is increasing in people with schizophrenia at about the same rate as in the general population but it remains well below what others can expect, a study from Finland suggests (Acta Psychiatrica Scand 2018; doi.org/10.1111/acps.12913).
Age at death and standardised mortality ratio (SMR) were …

More details...

NHS England helps service users raise concerns

NHS England has published a guide for patients, families and carers of people with a learning disability and autistic people to help them provide feedback, raise concerns and make complaints about education, health and social care services.
The 8-page booklet Ask Listen Do. Making conversations count …

More details...

Treatment for female hyposexual desire disorder edges closer

Palatin Technologies has applied to the US Food and Drug Administration for marketing approval for melanocortin-receptor-4 agonist bremelanotide for the treatment of female hyposexual desire disorder.
Palatin says the two 24-week Phase III RECONNECT trials involving over 1200 women – so far unpublished – have …

More details...

Europe agrees measures to stop valproate use during pregnancy

European states are set to ban valproate for treating migraine or bipolar disorder and to limit its use to treat epilepsy as a last resort. Women or girls of childbearing age for whom it is prescribed will be required to join a pregnancy prevention programme …

More details...

Developments in treatments for MS

Roche’s monoclonal antibody ocrelizumab (Ocrevus) has become the first medicine licensed for the treatment of primary progressive multiple sclerosis (PPMS) following EU approval in January. It is also licensed for relapsing MS (RMS), an indication that now has a wide range of treatment options.
Ocrelizumab selectively …

More details...

Web design and marketing agency Leamington Spa